BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pather K, Augustine TN. Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo. Sci Rep 2020;10:19256. [PMID: 33159119 DOI: 10.1038/s41598-020-75779-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lloyd MR, Wander SA, Hamilton E, Razavi P, Bardia A. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role. Ther Adv Med Oncol 2022;14:175883592211136. [DOI: 10.1177/17588359221113694] [Reference Citation Analysis]
2 Xulu KR, Augustine TN. Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation. Int J Mol Sci 2021;22:4153. [PMID: 33923802 DOI: 10.3390/ijms22084153] [Reference Citation Analysis]